Miller GJ - Search Results

1

Molecular cloning and characterization of human FGF8 alternative messenger RNA forms.

Ghosh AK, Shankar DB, Shackleford GM, Wu K, T'Ang A, Miller GJ, Zheng J, Roy-Burman P. Ghosh AK, et al. Among authors: miller gj. Cell Growth Differ. 1996 Oct;7(10):1425-34. Cell Growth Differ. 1996. PMID: 8891346

2

The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells.

Song Z, Powell WC, Kasahara N, van Bokhoven A, Miller GJ, Roy-Burman P. Song Z, et al. Among authors: miller gj. Cancer Res. 2000 Dec 1;60(23):6730-6. Cancer Res. 2000. PMID: 11118059

3

Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues.

Zheng J, Rudra-Ganguly N, Miller GJ, Moffatt KA, Cote RJ, Roy-Burman P. Zheng J, et al. Among authors: miller gj. Am J Pathol. 1997 Jun;150(6):2009-18. Am J Pathol. 1997. PMID: 9176394 Free PMC article.

4

Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?

Roy-Burman P, Zheng J, Miller GJ. Roy-Burman P, et al. Among authors: miller gj. Mol Med Today. 1997 Nov;3(11):476-82. doi: 10.1016/S1357-4310(97)01126-X. Mol Med Today. 1997. PMID: 9430782

5

Mouse strains for prostate tumorigenesis based on genes altered in human prostate cancer.

Powell WC, Cardiff RD, Cohen MB, Miller GJ, Roy-Burman P. Powell WC, et al. Among authors: miller gj. Curr Drug Targets. 2003 Apr;4(3):263-79. doi: 10.2174/1389450033491145. Curr Drug Targets. 2003. PMID: 12643476 Review.

6

Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer.

Mirchandani D, Zheng J, Miller GJ, Ghosh AK, Shibata DK, Cote RJ, Roy-Burman P. Mirchandani D, et al. Among authors: miller gj. Am J Pathol. 1995 Jul;147(1):92-101. Am J Pathol. 1995. PMID: 7604888 Free PMC article.

7

TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin.

van Bokhoven A, Varella-Garcia M, Korch C, Miller GJ. van Bokhoven A, et al. Among authors: miller gj. Cancer Res. 2001 Sep 1;61(17):6340-4. Cancer Res. 2001. PMID: 11522622

8

Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31.

Hedlund TE, Moffatt KA, Miller GJ. Hedlund TE, et al. Among authors: miller gj. J Steroid Biochem Mol Biol. 1996 Jun;58(3):277-88. doi: 10.1016/0960-0760(96)00030-1. J Steroid Biochem Mol Biol. 1996. PMID: 8836163

9

Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, Lucia MS, Nordeen SK. Miller GJ, et al. Among authors: miller hl. Cancer Res. 2003 Sep 15;63(18):5879-88. Cancer Res. 2003. PMID: 14522913

10

Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.

Hedlund TE, Moffatt KA, Uskokovic MR, Miller GJ. Hedlund TE, et al. Among authors: miller gj. Clin Cancer Res. 1997 Aug;3(8):1331-8. Clin Cancer Res. 1997. PMID: 9815816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters